发明申请
US20100069427A9 Oxime and Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds and Methods
失效
肟和羟胺取代的咪唑并[4,5-c]环化合物和方法
- 专利标题: Oxime and Hydroxylamine Substituted Imidazo[4,5-c] Ring Compounds and Methods
- 专利标题(中): 肟和羟胺取代的咪唑并[4,5-c]环化合物和方法
-
申请号: US11884153申请日: 2006-02-10
-
公开(公告)号: US20100069427A9公开(公告)日: 2010-03-18
- 发明人: Tushar A. Kshirsagar , Gregory D. Lundquist, JR. , Joseph F. Dellaria , Matthew R. Radmer , Bernhard M. Zimmermann
- 申请人: Tushar A. Kshirsagar , Gregory D. Lundquist, JR. , Joseph F. Dellaria , Matthew R. Radmer , Bernhard M. Zimmermann
- 申请人地址: US MA WELLESLEY
- 专利权人: COLEY PHARMACEUTICAL GROUP, INC.
- 当前专利权人: COLEY PHARMACEUTICAL GROUP, INC.
- 当前专利权人地址: US MA WELLESLEY
- 国际申请: PCT/US2006/004737 WO 20060210
- 主分类号: A61K31/437
- IPC分类号: A61K31/437 ; C07D471/04 ; A61P35/00
摘要:
Imidazo[4,5-c] ring compounds, (e.g. imidazo[4,5-c]pyridines, imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydro imidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridine, and 6,7,8,9-tetrahydro imidazo[4,5-c]naphthyridine compounds) having an oxime or hydroxylamine substituent at the 2-position, pharmaceutical compositions containing the compounds, intermediates, and methods of making and methods of use of these compounds as immunomodulators, for modulating cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
公开/授权文献
信息查询
IPC分类: